US Patent Issued to The United States of America, as represented by the Secretary, Department of Health and Human Services on Aug. 25 for "Using machine learning and/or neural networks to validate stem cells and their derivatives (2-D cells and 3-D tissues) for use in cell therapy and tissue engineered products" (Maryland, District Of Columbia Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,718,601, issued on Aug. 25, was assigned to The United States of America, as represented by the Secretary, Department of Health and Human Services (Bethesda, Md.).

"Using machine learning and/or neural networks to validate stem cells and their derivatives (2-D cells and 3-D tissues) for use in cell therapy and tissue engineered products" was invented by Kapil Bharti (Potomac, Md.), Nathan A. Hotaling (Washington), Nicholas J. Schaub (Gaithersburg, Md.) and Carl G. Simon (Gaithersburg, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method is provided for non-invasively predicting characteristics of one or more cells and cell derivatives. The method...